Epigallocatechin gallate (EGCG)
Sponsors
National Health Research Institutes, Taiwan, The University of Texas Health Science Center at San Antonio, Yale University, Cairo University, University of Texas Southwestern Medical Center
Conditions
Cirrhosis, LiverColon CancerFibrosis; SkinIrreversible PulpitisNPCRadiation DermatitisRadiation Dermatitis AcuteUterine Fibroids
Early Phase 1
Phase 1
Phase 2
Phase 3
Unknown Phase
Epstein-Barr Virus Reactivation and the Effect of EGCG on Virus Reactivation in Remission Patients
CompletedNCT01744587
Start: 2013-04-30End: 2023-05-16Updated: 2025-08-15
Epigallocatechin Gallate (EGCG) as a Flushing Agent During Full Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis
Active, not recruitingNCT05811403
Start: 2023-07-01End: 2026-06-30Target: 64Updated: 2026-03-25